Healthcare Analytics, Population Health Management, Healthcare Big Data

Personalized Medicine

Consumers Curious About AI, Genetic Testing for Precision Medicine

September 26, 2018 - Healthcare consumers are cautious but optimistic that emerging strategies like artificial intelligence and advanced genetic testing can lead to better care for cancer, according to a new survey from McKesson and Ipsos. The poll of more than 2000 individuals found that close to two-thirds (60 percent) of respondents are open to the idea of using genetic testing to identify their risk of...


More Articles

Amazon, APIs to Support Cloud Informatics Platform for Life Sciences

by Jennifer Bresnick

Amazon Web Services (AWS), Accenture, and Merck have announced a collaboration to create a cloud-based informatics research platform to support advances in the life sciences. The project will accelerate drug development by improving...

Using Big Data, Machine Learning to Reduce Chronic Disease Spending

by Jessica Kent

Diabetes and heart disease are two of the most costly and prevalent chronic conditions impacting patients in the US, leading the healthcare industry to spend billions every year to treat and manage these disorders. As care delivery...

$21M Grant to “All of Us” Orgs Will Support Precision Medicine Research

by Jessica Kent

The HHS Health Resources and Services Administration (HRSA) has awarded $21 million to 46 community health centers to support their participation in NIH’s All of Us precision medicine research program. The grant will allow community...

How to Bring Precision Medicine into Routine Clinical Care

by Jessica Kent

Precision medicine has taken the healthcare industry by storm in recent years, offering the promise of more individualized treatments, improved patient outcomes, and a deeper understanding of genetic conditions and rare...

NCI Studies Link Dozens of Genetic Variants to Cancer

by Jessica Kent

The discovery of genetic variants that are associated with cancer development could assist providers with identifying high-risk patients and crafting precision medicine therapies for oncology, according to new research funded by the...

Broader Availability of Genetic Testing a Boon for Precision Care

by Jennifer Bresnick

Precision medicine is quickly moving out of the realm of science fiction and into the everyday routines of oncologists, neurologists, and other providers treating patients who may have had little hope just a few short years ago. While the...

Cleveland Clinic Sets Up New Biobank for Clinical, Genomic Research

by Jessica Kent

Cleveland Clinic and Brooks Automation have announced a new biobank facility to enhance research on human tissue samples and improve clinical care for several conditions, including cancer, heart disease, and epilepsy. "This new...

Genomic Medicine Initiatives Aid Undiagnosed Pediatric Patients

by Jessica Kent

Three pediatric medical centers have introduced genomic medicine initiatives aimed at accelerating diagnoses and treatment for children with unexplained illnesses. Nicklaus Children’s Hospital of Miami, in collaboration with Rady...

Intermountain Launches Prospective Precision Medicine Study

by Jennifer Bresnick

Intermountain Healthcare is launching a new precision medicine project that will allow researchers to take a prospective view on the potential of genomic data. The PRECISE study allows for the collection of fresh-frozen tissue and blood...

NIH Concludes In-Depth Genomic Data Analysis of 33 Cancer Types

by Jessica Kent

The National Institutes of Health (NIH) has completed detailed genomic data analysis of the PanCancer Atlas, a data set of molecular and clinical information from over 10,000 tumors that represent 33 types of cancer. “This project...

Henry Ford to Apply Data Analytics to Pancreatic Cancer with $20M Gift

by Jennifer Bresnick

An anonymous $20 million donation to Henry Ford Health System will help the health system leverage big data analytics for the early detection and better treatment of pancreatic cancer. The Henry Ford Pancreatic Cancer Center will focus on...

Healthy Nevada Study Combines Genomics, Population Health

by Jennifer Bresnick

A unique population health study in Nevada is combining genomic information from thousands of citizens with socioeconomic, environmental, and clinical data to develop insights into how lifestyle interacts with genetics. The Healthy Nevada...

Payers Starting to Tie Precision Medicine to Value-Based Care

by Jennifer Bresnick

Precision medicine has started to offer important answers to patients with diseases that have a genetic component, but covering the costs of cutting-edge testing and emerging therapies can be a challenge. Payers are often hesitant to...

Roche Buys Flatiron Cancer Analytics, EHR Tools for $1.9B

by Jennifer Bresnick

Swiss pharmaceutical giant Roche will purchase Flatiron Health’s cancer analytics assets for $1.9 billion in an effort to enhance the drug development process and further the progress of precision medicine. Flatiron Health, backed...

Big Data Analytics Fuels Penn State Precision Health Research

by Jessica Kent

Penn State researchers recently announced their plan to create a Digital Collaboratory for Precision Health Research that will leverage big data analytics to boost individualized care. Project collaborators hope to develop a secure health...

NIH Calls for “All of Us” Population Health Research Proposals

by Jennifer Bresnick

Update: The NIH has extended the submission deadline from February 9 to February 23, 2018. The National Institutes of Health (NIH) has put out an informal call for research proposals to harness its growing All of Us big data...

GE, Roche Partner for Big Data Analytics, Precision Medicine Platform

by Jennifer Bresnick

GE Healthcare and Roche Diagnostics have announced a collaboration aimed at developing a digital diagnostics platform providing clinical decision support for oncology and critical care.  The partnership will leverage both...

MIT Works to Align Pharmaceutical Development, Public Health Needs

by Jennifer Bresnick

A new project from the MIT Center for Biomedical Innovation aims to align innovative pharmaceutical development with real-world patient care and public health needs.  The Learning Ecosystems for Accelerating Patient-Centered and...

CMS Proposes Coverage for Next-Gen Precision Medicine Test

by Jennifer Bresnick

Precision medicine may be about to take a big leap forward as CMS considers covering the costs of a new, FDA-approved next-generation sequencing (NGS) test that can identify key biomarkers for certain cancers. The FoundationOne CDx...

X

Join 25,000 of your peers

Register for free to get access to all our articles, webcasts, white papers and exclusive interviews.

Our privacy policy

no, thanks

Continue to site...